Dr. José-Alain Sahel is a clinician-scientist who developed a groundbreaking neuroprotective strategy to rescue central vision and first-in-man studies with electronic retinal implants, gene and cell therapies to restore vision in patients with blinding retinal dystrophies. He led the clinical trial documenting for the first time partial visual recovery after optogenetic therapy in a blind patient.
University of Pittsburgh School of Medicine / Institut de la Vision (Sorbonne Université/Inserm/CNRS)
Content by this speaker
Further Activities to have a look at